SILVER SPRING, MARYLAND — U.S. Food and Drug Administration said on Tuesday that nine deaths from a rare form of cancer have been linked to breast implants. <br /> <br />The cancer is known as Breast Implant-Associated Anaplastic Large Cell Lymphoma. It usually develops in the effusion fluid surrounding the breast implant or is contained inside the fibrous scar capsule, according to the FDA. <br /> <br />The condition is not a type of breast cancer, but a rare cancer of the cells of the immune system that can also occur in other parts of the body, including the skin and the lymphatic system. <br /> <br />Women with breast implants have a very low, but increased risk of developing cancer than women who do not have breast implants. <br /> <br />The FDA received a total of 359 reports of breast Implant-Associated Anaplastic Large Cell Lymphoma as of February 1 this year. <br /> <br />The authority has emphasized that the cancer is rare and the type of implant fill does not appear to affect the risk of developing the cancer.
